Clincosm LogoSign in Get a demo

hepatocellular carcinoma recurrent

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Potential Chemoprevention Drugs in Recurrent Hepatocellular

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Surgery
  • No intervention for research purpose
  • Taichung, Taiwan
    China Medical University Hospital, Department of Surgery
Aug 5, 2023

Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent Trial in New York, Hong Kong, Singapore

Recruiting
  • Hepatitis B Virus Related Hepatocellular Carcinoma
  • Hepatocellular Carcinoma Recurrent
  • SCG101
  • New York, New York
  • +4 more
Nov 18, 2022

Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable Trial in San Antonio (OTX-2002, Tyrosine kinase

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • San Antonio, Texas
    Next Oncology
Aug 9, 2022

Post-orthotopic Liver Transplantation, Hepatocellular Carcinoma Recurrent Trial in Nanjing (Bevacizumab Biosimilar IBI305)

Not yet recruiting
  • Post-orthotopic Liver Transplantation
  • Hepatocellular Carcinoma Recurrent
  • Bevacizumab Biosimilar IBI305
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
May 5, 2022

Hepatocellular Carcinoma Recurrent Trial in Chongqing (Tislelizumab/Sintilimab+Lenvatinib/Bevacizumab, RFA)

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Chongqing, Chongqing, China
    Institute of hepatobiliary surgery,Southwest Hospital
Mar 11, 2022

hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Liver Transplant; Complications
  • liver transplant
  • +2 more
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 21, 2021

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent Trial in El Segundo (biological, drug, procedure)

Withdrawn
  • Hepatocellular Carcinoma Non-resectable
  • Hepatocellular Carcinoma Recurrent
  • ETBX-011
  • +17 more
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Mar 17, 2021

Liver Transplant; Complications, Hepatocellular Carcinoma Recurrent Trial in Shanghai (Pembrolizumab Injection [Keytruda],

Recruiting
  • Liver Transplant; Complications
  • Hepatocellular Carcinoma Recurrent
  • Pembrolizumab Injection [Keytruda]
  • Lenvatinib Oral Product
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Aug 12, 2020

Hepatocellular Carcinoma Recurrent Trial in Guangzhou (Tenofovir disoproxil fumarate 300mg, Entecavir 0.5 mg)

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Tenofovir disoproxil fumarate 300mg
  • Entecavir 0.5 mg
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 18, 2020

Hepatocellular Carcinoma Recurrent Trial in Chongqing (Laparoscopic Hepatectomy, Radiofrequency Ablation)

Unknown status
  • Hepatocellular Carcinoma Recurrent
  • Laparoscopic Hepatectomy
  • Radiofrequency Ablation
  • Chongqing, Chongqing, China
    Southwest Hospital
Oct 13, 2017

Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Carcinoma, Hepatocellular Trial in Worldwide

Terminated
  • Hepatocellular Carcinoma Non-resectable
  • +12 more
  • Beverly Hills, California
  • +162 more
Sep 7, 2012